When Everyone Survives Foundation Exceeds 1 Million in Research Funded
The When Everyone Survives Foundation has awarded four new grants representing a total investment of $1.15 million to tackle leukemia research.
 
Duluth, GA (July 1, 2014) –When Everyone Survives is pleased to award four leukemia research grants in 2014. The four recipients are: Chengcheng Zhang , PhD, University of Texas Southwestern Medical Center in Dallas, David Frank, MD, Phd, Dana-Farber Cancer Institute of the Harvard Medical School in Boston, Edmund K. Waller, MD, PhD, FACP, Winship Cancer Institute of Emory University School of Medicine in Atlanta , and Gang Huang, PhD of the Cincinnati Children's Hospital Medical Center in Cincinnati. Funding for all four initiatives will take place on July 1st and, at that time, the Foundation’s cumulative funding since inception will reach $1.15 million.  
 
“The research these Doctors are conducting were judged by our Medical Advisory Board to be innovative and likely to be curative against the fight of leukemia and other blood related cancers,” said W.E. “Bill” Smith, Founder and President of When Everyone Survives. “We are honored and excited to fund these research initiatives.”
 
In 2014, Drs. Langston, Lechowicz and Al-Kahdimi of Emory University/Winship Cancer Institute served on When Everyone Survives Medical Advisory Board. The Medical Advisory Board has been established to provide counsel and direction for the Foundation’s research efforts. Each year the Medical Advisory Board determines the most relevant, productive and promising research initiatives that, in their opinion, can most benefit from funding the Foundation is able to provide and give direction for distribution of those funds.
 
“Join us as we pray that these research efforts will be successful and provide the day When Everyone Survives,” Smith.
 
About When Everyone Survives
When Everyone Survives Foundation is a Gwinnett County Georgia based nonprofit established by the Smith family after their 22 year-old son, Wes, succumbed to leukemia in 2005. The Foundation’s primary purpose is that of collecting and distributing funds for leukemia research. From January 1- April 1, the Foundation accepts grant applications. Each year the Foundation provides $50,000 grants to the applicants chosen by the Medical Advisory Board. Funding decisions are announced June 1, and checks for funding are mailed July 1. The Foundation has now distributed $1.15 Million in leukemia research grants in only eight funding cycles.